Rapid Micro Biosystems (RPID) Stock Price, News & Analysis

Company Overview

Rapid Micro Biosystems, Inc. develops automated solutions for detecting and monitoring microbial contamination in pharmaceutical, biotechnology, and other regulated manufacturing environments. Its technologies are designed to help companies replace or reduce manual, labor-intensive microbiological testing processes while supporting quality control and regulatory compliance.

The company’s primary offering is the Growth Direct platform, an automated microbial detection system that combines instrumentation, consumables, and software. The platform is intended for applications such as environmental monitoring, water testing, and sterility testing. Rapid Micro Biosystems also provides related services, including implementation support, validation assistance, maintenance, and technical support.

Founded in 2005 and headquartered in Lowell, Massachusetts, Rapid Micro Biosystems serves customers in the biopharmaceutical and pharmaceutical industries, as well as other life sciences and regulated manufacturing markets. Its products are marketed for use in facilities in North America, Europe, and other international regions.

Key Stats

• Today's Range: $1.13 to $1.15
• 50-Day Range: $1.09 to $2.21
• 52-Week Range: $1.09 to $4.94
• Volume: 260,149 shs
• Average Volume: 255,739 shs
• Market Capitalization: $56.68 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Hold

Rapid Micro Biosystems Stock Analysis - MarketRank™

Rapid Micro Biosystems scored higher than 32% of companies evaluated by MarketBeat, and ranked 730th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Rapid Micro Biosystems has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Rapid Micro Biosystems has a consensus price target of $6.00, representing about 431.0% upside from its current price of $1.13.

Amount of Analyst Coverage

Rapid Micro Biosystems has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($0.91) to ($0.76) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Rapid Micro Biosystems is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Rapid Micro Biosystems is -1.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Rapid Micro Biosystems has a P/B Ratio of 1.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1.99% of the float of Rapid Micro Biosystems has been sold short.

Short Interest Ratio / Days to Cover

Rapid Micro Biosystems has a short interest ratio ("days to cover") of 4.48.

Change versus previous month

Short interest in Rapid Micro Biosystems has recently increased by 3.03%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Rapid Micro Biosystems does not currently pay a dividend.

Dividend Growth

Rapid Micro Biosystems does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Rapid Micro Biosystems this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.70% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/07/2026
• Today: 9/21/2026
• Small-Cap Virtual Conference: 9/23/2026
• Next Earnings (Estimated): 11/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:RPID
• CIK: 1380106
• Web: www.rapidmicrobio.com
• Phone: 978-349-3200
• Fax: N/A
• Employees: 171
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Rapid Micro Biosystems: $6.00
• High Price Target: $7.00
• Low Price Target: $5.00
• Potential Upside/Downside: +431.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$47.12 million
• Net Margins: -145.56%
• Pretax Margin: -145.34%
• Return on Equity: -177.04%
• Return on Assets: -73.12%

Debt

• Debt-to-Equity Ratio: 1.08
• Current Ratio: 2.55
• Quick Ratio: 1.51

Sales & Book Value

• Annual Sales: $33.59 million
• Price / Sales: 1.69
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.75 per share
• Price / Book: 1.51

Miscellaneous

• Outstanding Shares: 50,160,000
• Free Float: 43,790,000
• Market Cap: $56.68 million
• Optionable: Not Optionable
• Beta: 1.43